IPO registrations (S-1, F-1) · Registrants
GENAERA CORP
- SEC CIK
- 880431 · filings on EDGAR ↗
- Name on the registration
- MAGAININ PHARMACEUTICALS INC
- Former names
- MAGAININ PHARMACEUTICALS INC (1994–2001)
- Registration
- Form S-1, first filed 1999-09-28, last 1999-10-13; 1 initial registration, 1 amendment
- Outcome
- Final prospectus filed 1999-10-18
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 5110 CAMPUS DR, Plymouth Meeting, PA 19462
- EIN
- 13-3445668
- EDGAR entity type
- operating
- Insiders and CEO pay
- GENAERA CORP on the corporate pages
Offering terms
- Final price
- $1.00 per share (424B1 filed 1999-10-18)
- Shares sold
- 4,000,000
- Gross proceeds
- $4,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MAGN
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Genaera Corporation Fuzzy (name and state)
- SEC filer: GENAERA CORP EXACT (CIK (EXACT))
- Person page: Osagie O Imasogie Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 3
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1999-09-28 | S-1 | S-1 (registration) | MAGAININ PHARMACEUTICALS INC | 0001036050-99-001972 ↗ |
| 1999-10-13 | S-1/A | S-1/A (amendment) | MAGAININ PHARMACEUTICALS INC | 0001036050-99-002061 ↗ |
| 1999-10-18 | 424B1 | 424B1 (final prospectus) | MAGAININ PHARMACEUTICALS INC | 0001036050-99-002107 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1999-10-13 | S-1/A | registration statement | 4,000,000 | - | Nasdaq MAGN | 0 | from the submission text; shares headline | document ↗ | ||
| 1999-10-18 | 424B1 | final prospectus | $1.00 | 4,000,000 | $4,000,000 | Nasdaq MAGN | 0 | from the submission text; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ARMSTRONG JOHN L JR | Director,Officer; Officer | CEO; President and CEO; President & CEO | 20 | 2006–2008 | |
| IMASOGIE OSAGIE O | Director | 6 | 2006–2008 | person page Fuzzy | |
| ECOCK R FRANK | Director | 7 | 2006–2008 | ||
| LEVITT ROY C | Director | 3 | 2006 | ||
| Gast Michael J | Officer | Chief Medical Officer; EVP & Chief Medical Officer; EVP Clinical and Development; EVP Clinical and Research; Executive VP of Clin Research; SVP Clinical/ Development | 7 | 2006–2008 | |
| SAVINO PETER J | Director | 4 | 2006–2007 | ||
| SKOLAS JOHN A | Officer | EVP, CFO and General Counsel; EVP, CFO & General Counsel | 2 | 2006 | |
| HOROVITZ ZOLA P | Director | 4 | 2006–2008 | ||
| SHAPIRO ROBERT F | Director | 5 | 2006–2008 | ||
| WYNGAARDEN JAMES B | Director | 2 | 2006–2007 | ||
| Kelly Leanne M. | Officer | Sr. Vice President & CFO; Sr. VP and CFO; SVP & CFO; SVP & Chief Financial Officer | 6 | 2007–2008 | |
| Xmark Opportunity Partners, LLC | TenPercentOwner | 40 | 2007–2009 | ||
| Wolfe Henry R | Officer | EVP & Chief Scientific Officer | 3 | 2007–2008 | |
| Kaye Mitchell D | Director,TenPercentOwner | 14 | 2007–2009 | ||
| Wotton Paul K | Director | 3 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | GENAERA CORP | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | Genaera Corporation | State business registries | name and state | |
| Person page | Osagie O Imasogie | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), PA first:
- APOLLON INC PA
- Aevi Genomic Medicine, LLC PA
- Ocugen, Inc. PA
- Spark Therapeutics, Inc. PA
- Krystal Biotech, Inc. PA
- Cabaletta Bio, Inc. PA
- Passage BIO, Inc. PA
- Century Therapeutics, Inc. PA
- Aphton CORP PA
- Aceragen, Inc. PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health